Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...

The American College of Physicians says the term ‘provider’ blurs lines between nurse practitioners and physicians, confuses ...

The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental ...

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more ...

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

A consortium of telehealth companies and insurers has published its ‘National Telehealth Standards,’ but some question the document’s impact.

Invented by users and refined by engineers, wheelchairs now span €200 hospital loans to €30,000 custom models — a spectrum ...

Patients with IBD may experience increased serum levels of vitamin D with supplementation, but improvement in disease ...

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Oral anticoagulation alone is linked to lower risks for cardiovascular death and bleeding than adding an antiplatelet in ...